Incontinentia Pigmenti

Meet the patient

A newborn girl, born at term and well, is noted on day 2 to have linear, swirling vesicles tracking along the skin of the trunk and limbs in a pattern no dermatome explains. She is afebrile and feeding, but the white-cell count shows a striking eosinophilia. The registrar reaches for aciclovir, fearing neonatal herpes — until someone maps the lesions to Blaschko's lines.[1]

Hold the two questions that decide this baby's next week: is this neonatal herpes that I must not miss? (test it — untreated HSV is lethal) and does this newborn need an ophthalmology referral today? (yes — retinal detachment is silent now and preventable only if treated before it occurs). Everything below hangs off those two.[1][3]

What IP is — the cornerstone genetics topic

Incontinentia pigmenti is a rare X-linked dominant multisystem genodermatosis caused by mutation in the IKBKG gene (formerly NEMO, NF-kappaB Essential Modulator) at Xq28. The classic disease is a striking four-stage Blaschkoid cutaneous eruption with ectodermal anomalies of the teeth, eyes, central nervous system, hair and nails. It is also called Bloch-Sulzberger or Bloch-Siemens syndrome.[1][2]

IP is the best clinical example of X-linked dominant inheritance with male lethality. Hemizygous affected males (XY) usually die in utero, so the overwhelming majority of live-born patients are female — the female-to-male ratio among recognised cases is greater than 20 to 1. It is a cornerstone genetics topic because a single condition illustrates lyonisation, functional mosaicism, Blaschkoid embryological cell migration, and the developmental consequences of NF-kappaB signalling failure all at once.[1]

Why the name: incontinentia pigmenti was chosen because, in the hyperpigmented stage, melanin appears to have lost continence and spilled from the epidermis into the dermis. The term flags the central histological finding — melanin incontinence in the third stage — which is one of the most distinctive findings in dermatopathology.[1]

One condition, five mechanisms — why examiners love it

In a single disease, IP demonstrates five high-yield mechanisms, and examiners will ask any one of them:[1]

1. X-linked dominant inheritance with male lethality — hemizygous males die in utero.
2. X-inactivation (lyonisation) producing functional mosaicism — two populations of skin cells along Blaschko's lines.
3. Blaschkoid distribution of skin disease — the pathways of embryonic ectodermal migration, not nerves or dermatomes.
4. Loss of NF-kappaB anti-apoptotic signalling — mutant ectodermal cells die.
5. Multisystem ectodermal disease — skin, teeth, eyes, brain, hair and nails from one gene.[1]

The classic trap: assuming mild skin disease means mild systemic disease. A mother with barely visible stage-4 streaks can have a daughter with severe retinal disease, because the randomness of X-inactivation means the phenotype cannot be predicted from the family history alone. Every patient needs complete screening regardless of how mild the rash looks.[1]

Pathophysiology — molecular, cellular, and the four stages

At the molecular level, IKBKG encodes NEMO, the regulatory subunit of the IKK complex, which is essential for activating the canonical NF-kappaB pathway after stimulation by tumour necrosis factor, interleukin-1, and Toll-like receptors. Without functional NEMO, NF-kappaB cannot translocate to the nucleus, so the survival genes it drives — anti-apoptotic factors such as BCL-xL and c-IAPs — are not transcribed, and the cell becomes vulnerable to tumour-necrosis-factor-mediated apoptosis. The common deletion of exons 4 to 10 accounts for up to 80 percent of cases.[1]

At the cellular level, lyonisation creates two populations of skin cells: those in which the mutant X is active (and tend to die) and those in which the normal X is active (and survive). Mutant cells are lost or outcompeted, producing the characteristic pattern of affected skin alternating with normal skin along Blaschko's lines — the embryonic ectodermal migration pathways, which are why IP produces swirling, linear and whorled patterns rather than dermatomal ones. The degree of X-inactivation skewing varies between tissues, which is why two affected sisters can have very different phenotypes.[1]

At the clinical level, the four cutaneous stages reflect the evolving response to mutant-cell apoptosis and inflammation:[1]

• Stage 1 — vesicular. Intense spongiosis with eosinophils, the immune response to dying keratinocytes.
• Stage 2 — verrucous. Hyperkeratotic, papillomatous repair as the epidermis regenerates over previous damage — a reactive proliferation, not a viral wart.
• Stage 3 — hyperpigmented. Melanin released from damaged basal keratinocytes is taken up by dermal melanophages — the melanin incontinence that names the disease.
• Stage 4 — atrophic or hypopigmented. Reduced epidermal thickness and appendage loss in affected clones, leaving pale, hairless, atrophic streaks.[1]

The four-stage Blaschkoid eruption — the spine of the topic

The four stages follow Blaschko's lines and may overlap in time and site, so one infant can show stage 1 vesicles on the trunk and stage 2 verrucous papules on the limbs at the same time. The classic teaching set:[1]

[1] [4]

Everyone forgets: an adult woman may show only stage-4 streaks, with the neonatal blistering long forgotten — so a careful history of neonatal blistering, dental anomalies, or family history is what makes the diagnosis in adulthood, not the skin alone.[1]

Extracutaneous disease — teeth, eyes, brain, hair, nails

[1]

Dental anomalies (over 90 percent) are the most consistent extracutaneous feature and can be the first clue in mild cases: peg-shaped or conical teeth, hypodontia or partial anodontia, delayed dentition, and malformed crowns, with the maxillary incisors most often affected. Panoramic radiography reveals the full extent and guides early restorative care.[2]

Ocular involvement (about 30 to 35 percent) is the most serious extracutaneous complication. The core problem is retinal vascular abnormality: the peripheral retina fails to vascularise normally, leading to avascular retina, neovascularisation, proliferative retinopathy, and retinal detachment. Other findings include strabismus, microphthalmia, cataracts, optic atrophy, and keratoconus. Retinal disease is asymptomatic in the neonatal period — which is why screening must precede symptoms.[3]

Neurological involvement (about 30 percent) includes seizures (infantile spasms, focal or generalised), developmental delay, intellectual disability, motor delay, spasticity, and rarely stroke-like episodes from cerebral vasculopathy. Neurological injury is usually early and permanent.[1]

Hair and nails show patchy scarring alopecia at the vertex, coarse or woolly hair, and nail dystrophy. Breast and skeletal anomalies (supernumerary nipples, breast hypoplasia, skull asymmetry) are uncommon.[1]

The preventable harm — why ophthalmology is the urgent referral

[3]

The rationale for laser is the same as in retinopathy of prematurity: ablating the avascular peripheral retina removes the angiogenic drive and reduces the risk of tractional detachment. Once detachment has developed, vitreoretinal surgery has a poor visual prognosis — so the treatment that works is the one given before symptoms, which is why ophthalmology is the most urgent referral in IP.[3]

The other acute priority is the seizure or altered consciousness: manage with standard paediatric or adult emergency protocols — airway protection, oxygen, glucose correction, and anticonvulsant therapy (a benzodiazepine for acute control, then levetiracetam or sodium valproate by age and seizure type) — and arrange urgent brain MRI and neurological referral.[1]

The differential — by stage, with the discriminator

The differential changes with the stage of skin disease, which is why examiners ask for a stage-matched list. A careful history of the four-stage progression, the Blaschkoid distribution, eosinophilia, and extracutaneous features usually distinguishes IP from its mimics.[1]

Stage 1 vesicular mimics: neonatal herpes simplex (grouped vesicles, systemic illness, positive PCR — exclude it in any unwell neonate), bullous impetigo (flaccid bullae, positive staphylococcal culture), epidermolysis bullosa (mechanical blisters at trauma sites), linear IgA bullous dermatosis (string of pearls, linear IgA on DIF), and bullous pemphigoid (tense bullae in the elderly). The discriminator is that Blaschkoid distribution plus eosinophilia plus eosinophilic spongiosis points to IP — but test for HSV regardless, because untreated neonatal herpes is life-threatening.[1]

Stage 2 verrucous mimics: epidermal naevus (linear hyperkeratotic plaque from birth, no preceding vesicular stage), verruca vulgaris, and naevus sebaceous. Stage 3 hyperpigmented mimics: linear and whorled nevoid hypermelanosis, lichen striatus, linear psoriasis, Blaschkoid lichen planus — none with the four-stage progression.[1]

Stage 4 atrophic mimics: hypomelanosis of Ito (streaky hypopigmentation with neurological and musculoskeletal anomalies, but no preceding stages and no IP dental anomalies; chromosomal mosaicism) and Goltz syndrome (focal dermal hypoplasia) — also X-linked dominant and male-lethal, but with linear atrophic lesions showing fat herniation, osteopathia striata, and papillomas, from PORCN mutation. Fat herniation in a linear atrophic lesion is Goltz, not IP.[1]

Investigations — biopsy by stage, confirm by genetics

Diagnosis is usually clinical, supported by skin biopsy and confirmed by genetic testing. Stage-1 histology is the most pathognomonic: eosinophilic spongiosis — intraepidermal spongiosis with numerous eosinophils and dyskeratotic keratinocytes. Stage 3 shows melanin incontinence with dermal melanophages; stage 4 shows epidermal atrophy and absent appendages.[4]

Peripheral blood eosinophilia is common in stage 1 and may be marked. If recurrent infections suggest the NEMO-related immunodeficiency overlap (anhidrotic ectodermal dysplasia with immunodeficiency), check serum immunoglobulins and lymphocyte subsets.[1]

Genetic testing confirms the diagnosis and enables family counselling. The common deletion of exons 4 to 10 of IKBKG must be sought by deletion or duplication analysis, not sequencing alone; sequence analysis catches point mutations and small indels. Prenatal diagnosis is available for a known familial mutation.[1][5]

Management — multidisciplinary, supportive, surveillance-based

There is no curative treatment. Management is multidisciplinary, supportive and surveillance-based, coordinated by dermatology or paediatrics, with the goal of preventing preventable complications — especially blindness — and supporting development.[1]

[1]

For the skin, stage 1 vesicles take gentle wound care, emollients, and a short course of a topical corticosteroid for inflammation, with antibiotics for secondary infection; stage 2 verrucous lesions take emollients and a keratolytic such as salicylic acid or urea; stage 3 pigmentation usually fades spontaneously; and stage 4 atrophic streaks take emollients, sun protection, and camouflage, with no treatment that reverses the atrophy.[1]

Genetic counselling — the 50 percent risk and the male losses

Explain X-linked dominant inheritance with male lethality with a clear family tree. An affected mother has a 50 percent chance of transmitting the mutation to each child: daughters who inherit it will be affected (with variable expressivity from random X-inactivation), and sons who inherit it usually die in utero — which is why many families carry a history of recurrent male miscarriages and excess female offspring.[1]

Offer prenatal diagnosis when the familial mutation is known: chorionic villus sampling at 11 to 14 weeks or amniocentesis at 15 to 18 weeks. Fetal sexing is usually offered first, because male fetuses carrying the mutation are almost always affected lethally. Screen at-risk female relatives for subtle skin, dental, or ocular findings — an adult woman may not know she has IP until examined carefully.[1]

The rare affected male should prompt consideration of Klinefelter syndrome (47,XXY) — the second X allows lyonisation and a female-like mosaic — or postzygotic somatic mosaicism, which produces a milder patchy phenotype and may transmit if the germline is involved. Paternal gonadal mosaicism can transmit an apparently de novo mutation to several children from an unaffected father.[1]

Complications, pitfalls, and prognosis

The most serious and most preventable complication is retinal detachment and blindness — failure to perform early dilated fundoscopy is the major pitfall, because once tractional detachment occurs, visual recovery is poor. Neurological disability from seizures, cognitive impairment, and stroke-like infarcts is usually established early. Severe hypodontia and peg-shaped teeth cause malocclusion, speech and feeding difficulty, and psychosocial distress.[1][3]

The recurring diagnostic pitfalls: treating neonatal IP as herpes simplex and delaying the correct diagnosis (test HSV, but recognise that Blaschkoid distribution plus eosinophilia favours IP); missing adult IP when only stage-4 streaks remain; and assuming mild skin disease means mild systemic disease.[1]

With modern multidisciplinary care, most patients have a normal lifespan. Quality of life turns on cosmetic appearance, visual outcome, neurological disability, and the burden of long-term follow-up. The skin disease does not predispose to skin cancer, and most patients can be managed as outpatients with coordinated multispecialty follow-up.[1]

The viva honesty line, and the mnemonic

The viva honesty line: "IP is X-linked dominant from IKBKG/NEMO on Xq28, lethal in most males. I read it through the four Blaschkoid stages — vesicular, verrucous, hyperpigmented, atrophic — with eosinophilic spongiosis in stage 1 and melanin incontinence in stage 3. I screen the teeth, eyes, brain, hair and nails, and the urgent referral is ophthalmology, because retinal detachment is silent and preventable with laser. I counsel the 50 percent transmission risk and the male losses, and I manage with a multidisciplinary team — there is no cure."[1]

[1]

Ward-round test — three stems, thirty seconds each

Stem 1 — the newborn with linear vesicles and eosinophilia (answer)

A 2-day-old girl has swirling linear vesicles along the trunk and limbs, no fever, and a marked peripheral eosinophilia. The registrar plans to start aciclovir for presumed neonatal herpes. What is the diagnosis, and what is the first thing you must not delay? Model: The Blaschkoid distribution plus eosinophilia plus a well infant points to incontinentia pigmenti, stage 1 — but neonatal herpes must still be tested and excluded by vesicle PCR, because untreated HSV is lethal. The referral not to delay is urgent ophthalmology: dilated indirect fundoscopy to find avascular peripheral retina, because retinal detachment is silent now and preventable only with early laser photocoagulation. Confirm IP with a skin biopsy (eosinophilic spongiosis) and IKBKG/NEMO genetic testing.[1][3]

Stem 2 — the adult woman with pale streaks (answer)

A 28-year-old woman presents with pale, hairless, atrophic streaks on the trunk and vertex scarring alopecia, and a history she vaguely recalls of "blistering as a baby". She has had poor vision in one eye since childhood. What is the diagnosis, and why does the family history matter? Model: This is stage-4 incontinentia pigmenti — atrophic hypopigmented streaks and vertex alopecia are the lifelong residual signs, and the childhood visual loss reflects prior retinal disease. The family history matters because IP is X-linked dominant with male lethality: each daughter has a 50 percent chance of being affected (with a phenotype independent of the mother's, from random X-inactivation), and affected male conceptuses usually die in utero — so a history of recurrent male miscarriages is a classic clue. Screen at-risk female relatives, and offer genetic counselling and prenatal diagnosis.[1]

Stem 3 — the male infant with a Blaschkoid rash (answer)

A male newborn has a Blaschkoid vesicular rash and eosinophilia. IP is suspected, but "IP is female-limited". How do you reconcile this, and what must you consider? Model: Affected males are rare but real, and two mechanisms allow survival: Klinefelter syndrome (47,XXY), where the second X permits lyonisation and a female-like mosaic pattern, and postzygotic somatic mosaicism, which produces a milder patchy phenotype and may transmit if the germline is involved. Consider NEMO-related immunodeficiency overlap if infections recur. Manage with the same multidisciplinary approach, plus endocrine and fertility counselling if Klinefelter is confirmed.[1]

References

1. [1]Rosser T. Incontinentia pigmenti Semin Pediatr Neurol, 2024.PMID 39389657
2. [2]Cammarata-Scalisi F, Fusco F, Ursini MV. Incontinentia Pigmenti Actas Dermosifiliogr (Engl Ed), 2019.PMID 30660327
3. [3]Islam YFK, Khurshid SG. Incontinentia pigmenti and the eye Curr Opin Ophthalmol, 2022.PMID 35819905
4. [4]Poziomczyk CS, Recuero JK, Bringhenti L, et al. Incontinentia pigmenti An Bras Dermatol, 2014.PMID 24626645
5. [5]Scheuerle AE, Ursini MV. Incontinentia Pigmenti 1993.PMID 20301645